|
1
|
Donepudi MS, Kondapalli K, Amos SJ and
Venkanteshan P: Breast cancer statistics and markers. J Cancer Res
Ther. 10:506–511. 2014.PubMed/NCBI
|
|
2
|
DeSantis CE, Fedewa SA, Sauer Goding A,
Kramer JL, Smith RA and Jemal A: Breast cancer statistics, 2015:
Convergence of incidence rates between black and white women. CA
Cancer J Clin. 66:31–42. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
DeSantis CE, Siegel RL, Sauer AG, Miller
KD, Fedewa SA, Alcaraz KI and Jemal A: Cancer statistics for
African Americans, 2016: Progress and opportunities in reducing
racial disparities. CA Cancer J Clin. 66:290–308. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ufen MP, Köhne CH, Wischneswky M, Wolters
R, Novopashenny I, Fischer J, Constantinidou M, Possinger K and
Regierer AC: Metastatic breast cancer: Are we treating the same
patients as in the past? Ann Oncol. 25:95–100. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zervoudis S, Iatrakis G, Tomara E, Bothou
A, Papadopoulos G and Tsakiris G: Main controversies in breast
cancer. World J Clin Oncol. 5:359–373. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Marino N, Woditschka S, Reed LT, Nakayama
J, Mayer M, Wetzel M and Steeg PS: Breast cancer metastasis: Issues
for the personalization of its prevention and treatment. Am J
Pathol. 183:1084–1095. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nalejska E, Mączyńska E and Lewandowska
MA: Prognostic and predictive biomarkers: Tools in personalized
oncology. Mol Diagn Ther. 18:273–284. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gasparri ML, Casorelli A, Bardhi E,
Besharat AR, Savone D, Ruscito I, Farooqi AA, Papadia A, Mueller
MD, Ferretti E and Panici Benedetti P: Beyond circulating microRNA
biomarkers: Urinary microRNAs in ovarian and breast cancer. Tumor
Biol. 39:10104283176955252017. View Article : Google Scholar
|
|
11
|
Ye N, Wang B, Quan ZF, Cao SJ, Wen XT,
Huang Y, Huang XB, Wu R, Ma XP and Yan QG: Functional roles of long
non-coding RNA in human breast cancer. Asian Pac J Cancer Prev.
15:5993–5997. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pendino F, Nguyen E, Jonassen I, Dysvik B,
Azouz A, Lanotte M, Ségal-Bendirdjian E and Lillehaug JR:
Functional involvement of RINF, retinoid-inducible nuclear factor
(CXXC5), in normal and tumoral human myelopoiesis. Blood.
113:3172–3181. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kühnl A, Valk PJ, Sanders MA, Ivey A,
Hills RK, Mills KI, Gale RE, Kaiser MF, Dillon R, Joannides M, et
al: Downregulation of the Wnt inhibitor CXXC5 predicts a better
prognosis in acute myeloid leukemia. Blood. 125:2985–2994. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bruserud Ø, Reikvam H, Fredly H, Skavland
J, Hagen KM, van Hoang TT, Brenner AK, Kadi A, Astori A, Gjertsen
BT and Pendino F: Expression of the potential therapeutic target
CXXC5 in primary acute myeloid leukemia cells-high expression is
associated with adverse prognosis as well as altered intracellular
signaling and transcriptional regulation. Oncotarget. 6:2794–2811.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yasar P, Ayaz G and Muyan M:
Estradiol-estrogen receptor α mediates the expression of the CXXC5
gene through the estrogen response element-dependent signaling
pathway. Sci Rep. 6:378082016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Knappskog S, Myklebust LM, Busch C,
Aloysius T, Varhaug JE, Lønning PE, Lillehaug JR and Pendino F:
RINF (CXXC5) is overexpressed in solid tumors and is an unfavorable
prognostic factor in breast cancer. Ann Oncol. 22:2208–2215. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jézéquel P, Campone M, Gouraud W,
Guérin-Charbonnel C, Leux C, Ricolleau G and Campion L:
bc-GenExMiner: An easy-to-use online platform for gene prognostic
analyses in breast cancer. Breast Cancer Res Treat. 131:765–775.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tabariès S, Ouellet V, Hsu BE, Annis MG,
Rose AA, Meunier L, Carmona E, Tam CE, Mes-Masson AM and Siegel PM:
Granulocytic immune infiltrates are essential for the efficient
formation of breast cancer liver metastases. Breast Cancer Res.
17:452015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Barrett T, Wilhite SE, Ledoux P,
Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH,
Sherman PM, Holko M, et al: NCBI GEO: Archive for functional
genomics data sets-update. Nucleic Acids Res. 41:(Database Issue).
D991–D995. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Badowska-Kozakiewicz AM and Budzik MP:
Immunohistochemical characteristics of basal-like breast cancer.
Contemp Oncol (Pozn). 20:436–443. 2016.PubMed/NCBI
|
|
21
|
Zhang M, Wang R, Wang Y, Diao F, Lu F, Gao
D, Chen D, Zhai Z and Shu H: The CXXC finger 5 protein is required
for DNA damage-induced p53 activation. Sci China C Life Sci.
52:528–538. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Astori A, Fredly H, Aloysius TA, Bullinger
L, Mansat-De Mas V, de la Grange P, Delhommeau F, Hagen KM, Récher
C, Dusanter-Fourt I, et al: CXXC5 (retinoid-inducible nuclear
factor, RINF) is a potential therapeutic target in high-risk human
acute myeloid leukemia. Oncotarget. 4:1438–1448. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Stoddart A, Qian Z, Fernald AA, Bergerson
RJ, Wang J, Karrison T, Anastasi J, Bartom ET, Sarver AL, McNerney
ME, et al: Retroviral insertional mutagenesis identifies the
del(5q) genes, CXXC5, TIFAB and ETF1, as well as the Wnt pathway,
as potential targets in del(5q) myeloid neoplasms. Haematologica.
101:e232–e236. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cui Z, Shen Y, Chen KH, Mittal SK, Yang JY
and Zhang G: KANK1 inhibits cell growth by inducing apoptosis
though regulating CXXC5 in human malignant peripheral nerve sheath
tumors. Sci Rep. 7:403252017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bettin A, Reyes I and Reyes N: Gene
expression profiling of prostate cancer-associated genes identifies
fibromodulin as potential novel biomarker for prostate cancer. Int
J Biol Markers. 31:e153–e162. 2016. View Article : Google Scholar : PubMed/NCBI
|
